GlassScriptPhysician profile
Daniel James Merenda
NPI 1265519680
$9,635.07
in general payments reported to CMS, 2019-2025
17 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2020: $730 · 2021: $653 · 2022: $1,812 · 2023: $2,617 · 2024: $1,576 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,280 · Consulting Fee: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,280.40 |
| Consulting Fee | $974.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $5,517.23 | 2019-2025 | |
| Genzyme Corporation | $1,223.81 | 2022-2023 | |
| Acclarent, INC | $774.64 | 2019-2022 | |
| Smith+Nephew, INC. | $456.27 | 2019-2024 | Coblation |
| Stryker Corporation | $403.22 | 2020-2025 | 1788, Latera, N/A |
| Regeneron Healthcare Solutions, INC. | $229.29 | 2022-2025 | Dupixent |
| Intersect Ent, INC. | $221.04 | 2019 | |
| Integra Lifesciences Corporation | $163.35 | 2023-2024 | Instruments-Orthopedic, Integra Duo, Integra |
| Medtronic, INC. | $146.59 | 2021-2023 | Propel, Nim Vital |
| Hologic Sales and Service, LLC | $132.08 | 2022-2024 | Coolseal Generator |
| Ars Pharmaceuticals Operations, INC. | $121.25 | 2025 | Neffy |
| E.R. Squibb & Sons, L.L.C. | $98.78 | 2019 | |
| Medtronic USA, INC. | $77.54 | 2019 | |
| Merck Sharp & Dohme LLC | $31.24 | 2025 | Keytruda |
| Pacira Pharmaceuticals Incorporated | $13.80 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.61 | 2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Merenda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.